Mastri et al., 2021 - Google Patents
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartmentMastri et al., 2021
View HTML- Document ID
- 2420078832615201417
- Author
- Mastri M
- Ramakrishnan S
- Shah S
- Karasik E
- Gillard B
- Moser M
- Farmer B
- Azabdaftari G
- Chatta G
- Woloszynska A
- Eng K
- Foster B
- Huss W
- Publication year
- Publication venue
- American Journal of Clinical and Experimental Urology
External Links
Snippet
The evolving paradigm of the molecular classification of bladder cancer requires models that represent the classifications with less heterogeneity. Robust transcriptome based molecular classifications are essential to address tumor heterogeneity. Patient derived models (PDMs) …
- 206010005003 Bladder cancer 0 title abstract description 30
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nie et al. | Single-cell analysis of human testis aging and correlation with elevated body mass index | |
| Grassi et al. | Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases | |
| Hirz et al. | Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses | |
| Rubin et al. | Impact of lineage plasticity to and from a neuroendocrine phenotype on progression and response in prostate and lung cancers | |
| Cazet et al. | Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer | |
| Boumahdi et al. | SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma | |
| Damerell et al. | Molecular mechanisms underpinning sarcomas and implications for current and future therapy | |
| Kinchen et al. | Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease | |
| Xia et al. | Exosome‐mediated transfer of miR‐1260b promotes cell invasion through Wnt/β–catenin signaling pathway in lung adenocarcinoma | |
| Li et al. | Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq | |
| Ruiz et al. | Dysregulation of lysyl oxidase expression in lesions and endometrium of women with endometriosis | |
| Mastri et al. | Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartment | |
| Singh et al. | RNAi screen identifies essential regulators of human brain metastasis-initiating cells | |
| Kim et al. | A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression | |
| Cheng et al. | Single-cell analysis reveals urothelial cell heterogeneity and regenerative cues following cyclophosphamide-induced bladder injury | |
| Ness et al. | Multicellular tumor spheroids of human uveal melanoma induce genes associated with anoikis resistance, lipogenesis, and SSXs | |
| Pan et al. | Tumour vasculature at single-cell resolution | |
| Xu et al. | CD248+ cancer-associated fibroblasts: a novel prognostic and therapeutic target for renal cell carcinoma | |
| Naruse et al. | Re-expression of REG family and DUOX s genes in CRC organoids by co-culturing with CAFs | |
| Feng et al. | Upregulated SLC27A2/FATP2 in differentiated thyroid carcinoma promotes tumor proliferation and migration | |
| De Angelis et al. | An orthotopic patient-derived xenograft (PDX) model allows the analysis of metastasis-associated features in colorectal cancer | |
| Schwartz et al. | High‐resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD | |
| Mori et al. | Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients | |
| Rafatian et al. | Mybl2 rejuvenates heart explant‐derived cells from aged donors after myocardial infarction | |
| Pulz et al. | Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling |